Latest Respiratory diseases Stories
Early screening of patients with chronic obstructive pulmonary disease (COPD) may help to detect lung cancer at an earlier stage, according to a new study. The research, published online today (16 November 2011) in the European Respiratory Journal, suggests that if COPD can be detected at an earlier stage, this will also aid the early detection of lung cancer. The news comes on World COPD Day, which aims to improve awareness of the condition and care of people with COPD around the...
ZURICH, November 16, 2011 /PRNewswire/ -- - Updated international treatment guidelines confirm experts' views that prevention of COPD exacerbations should be of equal importance to relieving daily symptoms - New data confirms COPD patients are at increased risk during winter, experiencing an increase in exacerbations, increasing the risk of long-term damage and more rapid disease progression - Patients should...
As consumers seek answers tailored to their personal health needs, MedHelp provides a unique ability to improve doctor-patient communication and connect patients to the #1 respiratory hospital in the U.S. San Francisco, CA (PRWEB) November 14, 2011 MedHelp, the world’s largest health social network, and National Jewish Health, the #1 respiratory hospital in the United States located in Denver, CO, recently celebrated their tenth anniversary of partnering to provide consumers with...
MesoAuthority is the largest collection of resource sites on the internet for families and victims of mesothelioma and asbestos exposure. Los Angeles, CA (PRWEB) November 11, 2011 In an effort to help those families and victims of asbestos exposure and the deadly cancer mesothelioma with all legal needs, The Sizemore Law Firm is pleased to announce the launch of MesoAuthority.com. The largest collection of asbestos and mesothelioma resource sites on the internet, MesoAuthority.com...
SAN DIEGO, Nov. 10, 2011 /PRNewswire/ -- Synteract, Inc., a full-service, global contract research organization (CRO), and MediciNova, Inc., a publicly traded biopharmaceutical company focused on novel, small-molecule therapeutics for the treatment of serious diseases, will team up to support the American Lung Association (ALA) in California in their annual Fight For Air Walk through team participation and donations. The two companies also are working together on a Phase 2 trial studying...
Calls on VA to Screen Veterans at High Risk for Lung Cancer WASHINGTON, Nov. 9, 2011 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) salutes the nation's 22 million Veterans for their service to our country and calls on the Department of Veterans Affairs to institute CT screening for those at high risk for lung cancer. Admiral T. Joseph Lopez, USN (Ret.), chairman of the LCA Board of Directors, said, "The most meaningful way we can show gratitude to our veterans is to offer...
EXTON, Pa., Nov. 7, 2011 /PRNewswire/ -- Pharmaxis, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a unique, Level II Health Care Common Procedural Coding System (Level II HCPCS), commonly referred to as a J-code, to ARIDOL® (mannitol inhalation powder) Bronchial Challenge Test Kit, which is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used...
The Asbestos Legal Center pledges its support for new medical research and cutting-edge treatments at the VA of Los Angeles, providing new hope for veterans in the fight against mesothelioma. San Francisco, CA (PRWEB) November 05, 2011 For many U.S. Military Service veterans diagnosed with mesothelioma, an aggressive cancer caused by exposure to asbestos, the thought of seeking treatment at the Veteran’s Administration Hospital was an unsatisfactory proposition. Whether right or...
Study's authors show blood vessels support lung regeneration and their findings could potentially open the door to therapy for lung disorders Researchers at Weill Cornell Medical College say they have taken an important step forward in their quest to "turn on" lung regeneration -- an advance that could effectively treat millions of people suffering from respiratory disorders. In the Oct. 28 issue of the journal Cell, the research team reports that they have uncovered the biochemical...
REDWOOD CITY, Calif., Oct. 28, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. presented data elucidating the robust aerosol performance and physicochemical foundations of the Company's cosuspension technology which uses spray-dried, low-density porous particles to deliver drug microcrystals via pressurized metered dose inhalers (MDIs). Two posters were presented this week at the 25th American Association of Pharmaceutical Scientists annual meeting in Washington DC. "These results demonstrate...
